News Releases

Antananarivo– A new state-of-the-art laboratory has bolstered Madagascar’s efforts to survey and detect polioviruses and effectively respond to the threat of the disease and protect children from its devastating impacts. 

The laboratory, which is fully accredited by World Health Organization (WHO), was handed over today to the national authorities. Hosted at the Institut Pasteur de Madagascar in the capital, Antananarivo, the laboratory reinforces the country’s position as a regional pillar in rapid poliovirus detection and outbreak response.

Abuja – Health leaders, policymakers and development partners across Africa have renewed commitment to accelerate the implementation of the PEN-Plus strategy to significantly expand access to care for severe noncommunicable diseases (NCDs).

Brazzaville – Experts, policymakers and global health partners have called for stronger, coordinated action to prevent backsliding on progress made against vaccine-preventable diseases in the African Region, where millions of children are still at risk.

Dakar - On July 1, 2025, Senegal officially launched the introduction of the hexavalent vaccine into its Expanded Program on Immunization (EPI). Following in Mauritania's footsteps, Senegal is part of this regional dynamic of vaccine innovation. This vaccine is a combination that protects against six diseases: diphtheria, tetanus, whooping cough, hepatitis B, Haemophilus influenzae type B (Hib), and poliomyelitis. It replaces the pentavalent and inactivated polio vaccines (IPV), previously administered separately.